Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Myeloma, Smoldering”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04731844
What this trial is testing

Curcumin and Piperine in Patients on Surveillance for Monoclonal Gammopathy, Smoldering Myeloma or Prostate Cancer

Who this might be right for
Prostate CancerMultiple MyelomaSmoldering Multiple Myeloma (SMM)+1 more
University of Rochester 30
Testing effectiveness (Phase 2)Study completedNCT00112827
What this trial is testing

Melphalan and Radiation Therapy Followed By Lenalidomide in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant for Stage I, Stage II, or Stage III Multiple Myeloma

Who this might be right for
Refractory Multiple MyelomaSmoldering Multiple MyelomaStage I Multiple Myeloma+2 more
City of Hope Medical Center 54
Not applicableLooking for participantsNCT06895291
What this trial is testing

Whole Body MRI in Oncology

Who this might be right for
LymphomaAdvanced Prostate CancerAdvanced Breast Cancer+3 more
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 1,000
Not applicableActive Not RecruitingNCT04920084
What this trial is testing

A Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceSmoldering Multiple Myeloma
Memorial Sloan Kettering Cancer Center 23
Testing effectiveness (Phase 2)Ended earlyNCT01838369
What this trial is testing

A Phase II Study of BI-505 in Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
BioInvent International AB 4
Testing effectiveness (Phase 2)Ended earlyNCT00942422
What this trial is testing

Green Tea Extract in Treating Patients With Monoclonal Gammopathy of Undetermined Significance and/or Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition
Barbara Ann Karmanos Cancer Institute 8
Testing effectiveness (Phase 2)Looking for participantsNCT05841550
What this trial is testing

The TG01 Study With TG01/QS-21 Vaccine in Patients With High-risk Smouldering Multiple Myeloma and Multiple Myeloma

Who this might be right for
Multiple MyelomaSmoldering Multiple Myeloma
Oslo University Hospital 20
Not applicableLooking for participantsNCT05312255
What this trial is testing

Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma

Who this might be right for
Plasma Cell MyelomaRecurrent Plasma Cell MyelomaRefractory Plasma Cell Myeloma+1 more
Roswell Park Cancer Institute 175
Testing effectiveness (Phase 2)Study completedNCT01237054
What this trial is testing

Imaging in MGUS, SMM and MM

Who this might be right for
Multiple MyelomaSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 31
Not applicableStudy completedNCT00919139
What this trial is testing

S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.

Who this might be right for
Multiple MyelomaSmoldering MyelomaWaldenstrom's Macroglobulinemia+2 more
SWOG Cancer Research Network 190
Not applicableLooking for participantsNCT06383143
What this trial is testing

Promoting Diagnosis and Management of AL in Italy (ProDigALIty)

Who this might be right for
AL AmyloidosisSmoldering Multiple MyelomaMonoclonal Gammopathy of Undetermined Significance
Fondazione IRCCS Policlinico San Matteo di Pavia 760
Early research (Phase 1)Study completedNCT02492750
What this trial is testing

Lenalidomide and Dexamethasone With or Without Anakinra in Treating Patients With Early Stage Multiple Myeloma

Who this might be right for
Indolent Plasma Cell MyelomaPlasma Cell MyelomaSmoldering Plasma Cell Myeloma
Mayo Clinic 14
Testing effectiveness (Phase 2)Looking for participantsNCT06100237
What this trial is testing

Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

Who this might be right for
Multiple Myeloma
Carl Ola Landgren, MD, PhD 50
Testing effectiveness (Phase 2)WithdrawnNCT01660997
What this trial is testing

MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma

Who this might be right for
Multiple Myeloma
National Cancer Institute (NCI)
Not applicableNot Yet RecruitingNCT06987708
What this trial is testing

Evaluating the Impact of a 12-month Multi-Modal Lifestyle Management Intervention on Disease Relevant Biomarkers

Who this might be right for
Monoclonal Gammopathy of Uncertain SignificanceSmoldering Myeloma
Hackensack Meridian Health 67
Testing effectiveness (Phase 2)Ended earlyNCT01248455
What this trial is testing

A Phase II Trial of Anti-KIR in Smoldering Multiple Myeloma

Who this might be right for
Multiple MyelomaMyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 9
Not applicableEnded earlyNCT01109407
What this trial is testing

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Who this might be right for
Smoldering MyelomaMonoclonal Gammopathy of Undetermined Significance
National Cancer Institute (NCI) 225
Testing effectiveness (Phase 2)Study completedNCT02279394
What this trial is testing

E-PRISM: Phase II Trial of Elotuzumab Lenalidomide and Dexamethasone in High-Risk Smoldering Multiple Myeloma

Who this might be right for
Smoldering MyelomaSmoldering Multiple Myeloma
Dana-Farber Cancer Institute 51
Not applicableStudy completedNCT05565638
What this trial is testing

PROFAST Intervention in Precursor Multiple Myeloma

Who this might be right for
Cancer PreventionWeight LossSmoldering Waldenstrom Macroglobulinemia(WM)+3 more
Dana-Farber Cancer Institute 23
Testing effectiveness (Phase 2)Study completedNCT03839459
What this trial is testing

Denosumab for Smoldering Multiple Myeloma

Who this might be right for
Smoldering Multiple Myeloma
University of Rochester 20
Next Page